Patents Assigned to Boehringer Ingelheim Internatioal GmbH
  • Patent number: 12054525
    Abstract: The invention relates to PYY analogues having alanine at position 4, lysine at position 7, QRY as the C-terminal end and a half-life extending group. The analogues of the invention are soluble around pH 6 and 7. The invention also relates to pharmaceutical compositions comprising such PYY analogues, and to the medical use of the analogues.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: August 6, 2024
    Assignee: Boehringer Ingelheim Internatioal GmbH
    Inventors: Peter Wilhelm Haebel, Albert Brennauer, Charlotte Stahl Madsen, Soren Ljungberg Pedersen, Stefan Peters
  • Patent number: 9199998
    Abstract: The present invention relates to substituted quinazolines of formula (I) wherein X and Y are defined as in claim 1, the tautomers, stereoisomers, mixtures and salts thereof, which have valuable pharmacological properties, particularly an inhibitory effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: December 1, 2015
    Assignee: Boehringer Ingelheim Internatioal GmbH
    Inventors: Waldemar Pfrengle, Markus Frank, Thomas Klein